News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
10,455 Results
Type
Article (213)
Company Profile (13)
Press Release (10229)
Section
Business (2765)
Career Advice (5)
Deals (348)
Drug Development (1209)
Employer Resources (3)
FDA (210)
Job Trends (377)
News (4314)
Policy (269)
Tag
2027 Genetown Standard (1)
Academia (36)
Accelerated approval (1)
Allergies (2)
Alliances (591)
ALS (12)
Alzheimer's disease (38)
Antibody-drug conjugate (ADC) (17)
Approvals (226)
Artificial intelligence (10)
ASCO (21)
Autoimmune disease (7)
Automation (1)
Bankruptcy (3)
Best Places to Work (364)
BIO (1)
Biosimilars (1)
Biotechnology (12)
Bladder cancer (5)
Brain cancer (7)
Breast cancer (54)
Cancer (222)
Cardiovascular disease (3)
Career advice (4)
CAR-T (13)
Cell therapy (38)
Clinical research (1160)
Collaboration (49)
Compensation (66)
Complete response letters (2)
COVID-19 (16)
CRISPR (1)
C-suite (41)
Cystic fibrosis (1)
Data (302)
Depression (3)
Diabetes (7)
Diagnostics (103)
Digital health (1)
Diversity, equity & inclusion (2)
Drug discovery (6)
Duchenne muscular dystrophy (19)
Earnings (1003)
Employer resources (3)
Events (2541)
Executive appointments (32)
FDA (311)
Friedreich's ataxia (1)
Frontotemporal dementia (7)
Funding (35)
Gene editing (2)
Generative AI (1)
Gene therapy (16)
GLP-1 (14)
Government (38)
Guidances (7)
Healthcare (335)
Hematology (8)
IgA nephropathy (2)
Immunology and inflammation (6)
Indications (3)
Infectious disease (19)
Inflammatory bowel disease (7)
Influenza (1)
Intellectual property (10)
Interviews (1)
IPO (155)
Job creations (23)
Job search strategy (4)
Kidney cancer (2)
Layoffs (3)
Legal (52)
Liver cancer (1)
Lung cancer (19)
Lymphoma (9)
Machine learning (1)
Manufacturing (19)
MASH (2)
Medical device (244)
Medtech (265)
Mergers & acquisitions (220)
Metabolic disorders (15)
mRNA (3)
Multiple sclerosis (8)
Neurodegenerative disease (9)
Neuroscience (81)
NextGen: Class of 2026 (146)
Non-profit (101)
Obesity (4)
Opinion (2)
Ovarian cancer (4)
Pain (17)
Pancreatic cancer (24)
Parkinson's disease (6)
Patents (20)
Patient recruitment (31)
People (988)
Phase 1 (491)
Phase 2 (506)
Phase 3 (292)
Pipeline (289)
Postmarket research (33)
Preclinical (230)
Prostate cancer (11)
Radiopharmaceuticals (30)
Rare diseases (41)
Real estate (97)
Recruiting (1)
Regulatory (300)
Research institute (32)
Resumes & cover letters (1)
Rett syndrome (1)
RNA editing (1)
Series A (6)
Series B (4)
Service/supplier (1)
Sickle cell disease (13)
Sponsored (1)
Startups (38)
Vaccines (9)
Weight loss (1)
Women's health (6)
Date
Today (3)
Last 7 days (12)
Last 30 days (63)
Last 365 days (778)
2026 (462)
2025 (810)
2024 (955)
2023 (936)
2022 (925)
2021 (955)
2020 (732)
2019 (687)
2018 (518)
2017 (376)
2016 (394)
2015 (437)
2014 (326)
2013 (227)
2012 (275)
2011 (288)
2010 (260)
Location
Africa (10)
Alabama (1)
Arkansas (1)
Asia (236)
Australia (185)
California (256)
Canada (34)
China (19)
Colorado (4)
Connecticut (24)
Delaware (4)
Europe (1030)
Florida (79)
Georgia (3)
Idaho (1)
Illinois (50)
Indiana (33)
Iowa (1)
Japan (7)
Kentucky (2)
Maryland (21)
Massachusetts (420)
Michigan (1)
Minnesota (3)
Missouri (1)
New Hampshire (2)
New Jersey (43)
New York (52)
North Carolina (67)
North Dakota (1)
Northern California (81)
Ohio (5)
Pennsylvania (57)
Puerto Rico (1)
Rhode Island (2)
South America (9)
Southern California (154)
Tennessee (2)
Texas (498)
United States (1599)
Utah (4)
Virginia (2)
Washington D.C. (2)
Washington State (14)
Wisconsin (1)
10,455 Results for "Obsidian_Tx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obsidian Therapeutics
Obsidian Therapeutics is pioneering controllable cell and gene therapies to deliver transformative outcomes for patients with intractable diseases.
Press Releases
Obsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million
August 3, 2026
·
8 min read
Press Releases
Obsidian Therapeutics Announces First Patient Enrolled in the Registration-enabling Cohort of Phase 1/2 Agni-01 Study Evaluating Amsoki-cel (OBX-115) in Advanced Melanoma
August 5, 2026
·
6 min read
Press Releases
TLX591-Tx ProstACT SELECT Study Published in Cancers Journal
July 22, 2026
·
8 min read
Press Releases
Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement
April 15, 2026
·
13 min read
Press Releases
Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement
April 15, 2026
·
13 min read
Press Releases
Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test
July 15, 2026
·
6 min read
Press Releases
Obsidian Therapeutics to Present Phase 2 Clinical Data for OBX-115 in Advanced Melanoma in Oral Presentation at 2026 ASCO Annual Meeting
May 22, 2026
·
11 min read
Press Releases
Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer
July 20, 2026
·
8 min read
Press Releases
Obsidian Therapeutics Appoints Julie Feder as Chief Financial Officer
January 13, 2026
·
2 min read
1 of 1,046
Next
